Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.
<h4>Background</h4>The use of cetuximab in combination with platinum (P) plus 5-fluorouracil (F) has previously been demonstrated to be effective in the treatment of metastatic squamous cell cancer of head and neck (SCCHN). We investigated the efficacy and outcome of this protocol as a f...
Guardado en:
Autores principales: | Ramon Andrade de Mello, Sandra Gerós, Marcos Pantarotto Alves, Filipa Moreira, Isabel Avezedo, José Dinis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1853c6527bd840abb60a2677418f82d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cetuximab: its unique place in head and neck cancer treatment
por: Specenier P, et al.
Publicado: (2013) -
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Mohamedtaki A Tejani, et al.
Publicado: (2010) -
Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021) -
EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
por: Muhammad Imran Khan Wajid, et al.
Publicado: (2019) -
Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma
por: Kohei Okuyama, et al.
Publicado: (2021)